Citigroup’s Iovance Biotherapeutics IOVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.23M Buy
714,851
+176,539
+33% +$304K ﹤0.01% 2397
2025
Q1
$1.79M Buy
538,312
+54,270
+11% +$181K ﹤0.01% 2161
2024
Q4
$3.58M Buy
484,042
+275,278
+132% +$2.04M ﹤0.01% 1692
2024
Q3
$1.96M Buy
208,764
+70,582
+51% +$663K ﹤0.01% 2056
2024
Q2
$1.11M Sell
138,182
-401,713
-74% -$3.22M ﹤0.01% 2190
2024
Q1
$8M Sell
539,895
-214,013
-28% -$3.17M 0.01% 996
2023
Q4
$6.13M Sell
753,908
-183,511
-20% -$1.49M ﹤0.01% 1026
2023
Q3
$4.27M Buy
937,419
+310,118
+49% +$1.41M ﹤0.01% 1113
2023
Q2
$4.42M Sell
627,301
-635,344
-50% -$4.47M ﹤0.01% 1164
2023
Q1
$7.71M Buy
1,262,645
+743,295
+143% +$4.54M 0.01% 938
2022
Q4
$3.32M Sell
519,350
-50,824
-9% -$325K ﹤0.01% 1251
2022
Q3
$5.46M Buy
570,174
+90,702
+19% +$869K ﹤0.01% 1078
2022
Q2
$5.29M Buy
479,472
+389,174
+431% +$4.3M ﹤0.01% 1098
2022
Q1
$1.5M Sell
90,298
-151,661
-63% -$2.53M ﹤0.01% 1990
2021
Q4
$4.62M Buy
241,959
+119,208
+97% +$2.28M ﹤0.01% 1338
2021
Q3
$3.03M Sell
122,751
-91,074
-43% -$2.25M ﹤0.01% 1601
2021
Q2
$5.56M Buy
213,825
+48,618
+29% +$1.27M ﹤0.01% 1353
2021
Q1
$5.23M Buy
165,207
+116,958
+242% +$3.7M ﹤0.01% 1314
2020
Q4
$2.24M Buy
48,249
+7,661
+19% +$356K ﹤0.01% 1641
2020
Q3
$1.34M Sell
40,588
-240,519
-86% -$7.92M ﹤0.01% 1722
2020
Q2
$7.72M Buy
281,107
+159,671
+131% +$4.38M 0.01% 906
2020
Q1
$3.64M Buy
121,436
+52,597
+76% +$1.57M ﹤0.01% 1081
2019
Q4
$1.91M Sell
68,839
-95,547
-58% -$2.65M ﹤0.01% 1714
2019
Q3
$2.99M Buy
164,386
+47,778
+41% +$869K ﹤0.01% 1342
2019
Q2
$2.86M Buy
116,608
+76,831
+193% +$1.88M ﹤0.01% 1394
2019
Q1
$378K Sell
39,777
-204,277
-84% -$1.94M ﹤0.01% 2699
2018
Q4
$2.16M Buy
244,054
+218,275
+847% +$1.93M ﹤0.01% 1482
2018
Q3
$289K Buy
25,779
+6,750
+35% +$75.7K ﹤0.01% 2905
2018
Q2
$244K Buy
19,029
+870
+5% +$11.2K ﹤0.01% 2815
2018
Q1
$307K Sell
18,159
-40,201
-69% -$680K ﹤0.01% 2635
2017
Q4
$467K Buy
58,360
+54,095
+1,268% +$433K ﹤0.01% 2400
2017
Q3
$33K Buy
4,265
+3,320
+351% +$25.7K ﹤0.01% 3822
2017
Q2
$7K Sell
945
-4,743
-83% -$35.1K ﹤0.01% 4235
2017
Q1
$42K Sell
5,688
-36,245
-86% -$268K ﹤0.01% 3753
2016
Q4
$291K Buy
41,933
+27,242
+185% +$189K ﹤0.01% 3338
2016
Q3
$121K Buy
14,691
+3,427
+30% +$28.2K ﹤0.01% 3295
2016
Q2
$91K Sell
11,264
-32,413
-74% -$262K ﹤0.01% 3376
2016
Q1
$221K Buy
43,677
+23,557
+117% +$119K ﹤0.01% 3393
2015
Q4
$155K Sell
20,120
-354,887
-95% -$2.73M ﹤0.01% 3250
2015
Q3
$2.16M Sell
375,007
-578
-0.2% -$3.33K ﹤0.01% 1276
2015
Q2
$3.44M Buy
+375,585
New +$3.44M ﹤0.01% 1069